您的位置:
首页
>
农业专利
>
详情页
שימוש בתרכובת הנבחרת מ– 21– מתוקסי–17 אלפא–אצטוקסי–11 בטא– (4–n,n דימתילאמינופניל)–19–נורפרגנה–4, 9–דיאין–3, 20–דיאון ו– 17 אלפא–אצטוקסי– 11 בטא– (4– n, n דימתילאמינופניל)–19–נורפרגנה–4, 9 –דיאין–3, 20– דיאון בייצור תרופה
专利权人:
REPROS THERAPEUTICS INC.
发明人:
REPROS THERAPEUTICS INC.
申请号:
IL22182012
公开号:
IL221820A
申请日:
2012.09.06
申请国别(地区):
IL
年份:
2018
代理人:
摘要:
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods for treating endometriosis, dysmenorrhea, breast cancer, uterine fibroids and endometrial hyperproliferation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关专利
Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
PROGESTERONE ANTAGONISTS SUCH AS CDB-4214 IN THE TREATMENT OF EMBODIMETRIOSIS, UTERINE FIBROIDS, DYSMENORRHEA, BREAST CANCER ETC
PREGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, DYSMENORRHEA, BREAST CANCER ETC
PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, DYSMENORRHEA, BREAST CANCER ETC
PROGESTERONE ANTAGONISTS SUCH AS CDB-4124 IN THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, DYSMENORRHEA, BREAST CANCER, ETC.